Smith & Nephew REGENETEN Bioinductive Implant Shows Improved Recovery Times for Rotator Cuff Tears
By Azmed Devices Editorial Team
New randomized control trial data indicates the REGENETEN Bioinductive Implant significantly improves post-operative recovery times and healing rates for partial-thickness rotator cuff tears compared to traditional surgical repair.
Smith & Nephew recently announced positive results from a randomized control trial regarding the efficacy of its REGENETEN Bioinductive Implant. According to the company, the study confirms that patients treated with the implant in isolation for partial-thickness rotator cuff tears experienced significant improvements in recovery outcomes. The data suggests that the implant supports biological healing by facilitating new tissue formation, offering an effective alternative for patients suffering from these common shoulder injuries.
The clinical findings highlight substantial improvements in early recovery milestones. The company reported that, compared to traditional suture anchor repairs, patients using the REGENETEN Bioinductive Implant returned to daily activities significantly faster. Specifically, recovery time was halved for essential tasks, including returning to driving, office work, and moderate-intensity household chores. These milestones were achieved without compromising pain levels or tendon healing, as confirmed by 12-month MRI scans conducted during the study period.
Published in the Orthopaedic Journal of Sports Medicine, the study represents the third randomized control trial to demonstrate the benefits of the implant over traditional repair techniques. Researchers noted that participants enjoyed a better quality of life at both the six-week and three-month marks. Furthermore, the company reported that tendon healing rates at one year were comparable to those achieved through traditional suture anchor-based surgeries, reinforcing the clinical value of the bioinductive approach.
The significance of these findings is supported by recent revisions to the American Academy of Orthopaedic Surgeons Clinical Practice Guideline on the Management of Rotator Cuff Injuries. This updated guidance highlights the role of bioinductive implants in modern rotator cuff care. Since its market introduction in 2014, the REGENETEN Bioinductive Implant has been utilized in over 250,000 procedures globally, according to Smith & Nephew, establishing it as a transformative solution within the company’s Advanced Healing Solutions portfolio.
Source
This article summarizes an official Smith & Nephew announcement. Read the original press release at https://www.smith-nephew.com/en/news/2026/04/09/sn-regeneten-bioinductive-implant-shows-post-operative-recovery-times-halved. Product availability in Azerbaijan is subject to local registration; contact Azmed Devices for current status.
